Huang Y.H., Cai K., Xu P.P., Wang L., Huang C.X., Fang Y., Cheng S.,Sun X.J., Liu F., Huang J.Y., Ji M.M., Zhao W.L. CREBBP/EP300mutations promoted tumor progression in diffuse large B-cell lymphomathrough altering tumor-associated macrophage polarizationvia FBXW7-NOTCH-CCL2/CSF1 axis. The gene discussed is CCL2; the disease is neoplasm.